The Rangers' Late Surge Looked Like Progress. The Plus/Minus Column Says Otherwise.

Here is the number that should make every Rangers fan pause before celebrating the finish: Artemi Panarin, the team's best player and most reliable offensive force all season, ended 2026 at minus-11. Mika Zibanejad, the center who put up 42 points in 48 games, finished at minus-17. Will Cuylle, J.T. Miller, and Alexis Lafreniere were all minus-16. A team that went 6-4 to close the year and held opponents to 2.0 goals per game over that stretch still had its core forwards bleeding goals against at a rate that tells a very different story than the final-10-game highlight reel.

That defensive tightening — dropping from 3.4 goals allowed per game to 2.0 over the last 10 — is the kind of number that gets cited all offseason as proof of a turning point. And it did fuel a real winning streak. But ten games is a small canvas, and the broader season tells you what this roster actually was: a team that finished 34-48 with a negative goal differential, where nearly every forward who played meaningful minutes ended the year on the wrong side of even. The late surge was genuine in outcome; whether it reflected genuine structural improvement is a different question entirely.

What makes me skeptical is what happened beneath the surface of that run. Matt Rempe's ice time collapsed during those final 10 games, falling from around 11 minutes a night to 8 — a compression that preceded his placement on injured reserve. Meanwhile, Taylor Raddysh's role expanded sharply, his minutes jumping from roughly 11 to nearly 15 as the Rangers leaned on him down the stretch. That is not the signature of a team that found a sustainable formula. That is a team reshuffling the deck because one piece broke and another stepped into the gap. The 6-4 record was built on a rotated lineup, not a fixed one.

The offseason moves are an acknowledgment of exactly this. Trading Vincent Trocheck — another minus-11 finisher — and adding Pavel Dorofeyev addresses offensive production. Bringing in Joonas Korpisalo and acquiring a defenseman from Vancouver addresses the goaltending and blue-line concerns that plagued the full season. These are real, substantive moves. But the organizational reset under Quentin Dolan also introduces a layer of uncertainty that the roster moves alone cannot resolve. A 32-year-old stepping into day-to-day operations of a franchise that just went 34-48 is either the beginning of something new or a complication layered onto an already fragile rebuild. History on that question is not encouraging.

My read is this: the late-season defensive improvement was a data point worth noting, not a conclusion worth trusting. The minus ratings across the forward corps, the injury to Rempe, the reliance on a reshuffled lineup — these are the structural fingerprints of a team that caught a favorable run, not one that solved its problems. What the Rangers do with the Dorofeyev acquisition, whether Adam Fox — the one core player who finished in positive territory — can anchor a rebuilt blue line for a full season, and whether Korpisalo can stabilize a goaltending situation that was a genuine liability, will determine whether 2026's final 10 games were a preview or a footnote. The box score from October will tell us which one it was.